

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.01761244 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.01761244 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.01761244 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.01761244 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.01761244 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.01761244 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.87965343 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.73098503 |
| 9 | microglial cell activation (GO:0001774) | 5.26824734 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.18980478 |
| 11 | tryptophan catabolic process (GO:0006569) | 4.98470037 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 4.98470037 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 4.98470037 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.87417300 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.81069815 |
| 16 | behavioral response to nicotine (GO:0035095) | 4.76510773 |
| 17 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.61335161 |
| 18 | indolalkylamine metabolic process (GO:0006586) | 4.44508269 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.41603290 |
| 20 | response to peptidoglycan (GO:0032494) | 4.30761148 |
| 21 | tryptophan metabolic process (GO:0006568) | 4.29732345 |
| 22 | macrophage activation (GO:0042116) | 4.29054480 |
| 23 | positive regulation of antigen processing and presentation (GO:0002579) | 4.27311487 |
| 24 | fucose catabolic process (GO:0019317) | 4.16426472 |
| 25 | L-fucose metabolic process (GO:0042354) | 4.16426472 |
| 26 | L-fucose catabolic process (GO:0042355) | 4.16426472 |
| 27 | respiratory burst (GO:0045730) | 4.16046340 |
| 28 | response to host immune response (GO:0052572) | 4.14452515 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.14452515 |
| 30 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.13511617 |
| 31 | neutrophil activation (GO:0042119) | 4.12106839 |
| 32 | regulation of establishment of cell polarity (GO:2000114) | 4.10336340 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 4.07171698 |
| 34 | interkinetic nuclear migration (GO:0022027) | 4.06610501 |
| 35 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.06440198 |
| 36 | positive regulation of developmental pigmentation (GO:0048087) | 4.05672532 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 4.04905621 |
| 38 | granulocyte activation (GO:0036230) | 4.04822150 |
| 39 | regulation of pigment cell differentiation (GO:0050932) | 3.98118609 |
| 40 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.97690948 |
| 41 | neural tube formation (GO:0001841) | 3.97224944 |
| 42 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.94361274 |
| 43 | regulation of interferon-alpha production (GO:0032647) | 3.94020582 |
| 44 | cellular extravasation (GO:0045123) | 3.90648462 |
| 45 | pinocytosis (GO:0006907) | 3.88595711 |
| 46 | indole-containing compound metabolic process (GO:0042430) | 3.85565292 |
| 47 | positive regulation of interferon-alpha production (GO:0032727) | 3.80843614 |
| 48 | serotonin metabolic process (GO:0042428) | 3.76043734 |
| 49 | T cell migration (GO:0072678) | 3.73259998 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 3.73059755 |
| 51 | snRNA transcription (GO:0009301) | 3.72749172 |
| 52 | sulfation (GO:0051923) | 3.70612962 |
| 53 | regulation of hippo signaling (GO:0035330) | 3.70208591 |
| 54 | regulation of monocyte chemotaxis (GO:0090025) | 3.69676885 |
| 55 | positive regulation of macrophage differentiation (GO:0045651) | 3.68675410 |
| 56 | response to host (GO:0075136) | 3.68096631 |
| 57 | response to host defenses (GO:0052200) | 3.68096631 |
| 58 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.68096631 |
| 59 | tolerance induction (GO:0002507) | 3.68011323 |
| 60 | protein K48-linked deubiquitination (GO:0071108) | 3.67648167 |
| 61 | eosinophil chemotaxis (GO:0048245) | 3.64648527 |
| 62 | negative regulation of mast cell activation (GO:0033004) | 3.63914069 |
| 63 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.63404158 |
| 64 | negative regulation of sodium ion transport (GO:0010766) | 3.56051312 |
| 65 | primary amino compound metabolic process (GO:1901160) | 3.55647142 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.55466046 |
| 67 | neuronal action potential (GO:0019228) | 3.52857551 |
| 68 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.50712521 |
| 69 | positive regulation of lymphocyte migration (GO:2000403) | 3.49336534 |
| 70 | oxidative demethylation (GO:0070989) | 3.45379068 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 3.44778074 |
| 72 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.43268330 |
| 73 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.43268330 |
| 74 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.43268330 |
| 75 | regulation of mast cell activation (GO:0033003) | 3.42196086 |
| 76 | endosome to pigment granule transport (GO:0043485) | 3.41450640 |
| 77 | endosome to melanosome transport (GO:0035646) | 3.41450640 |
| 78 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.41147723 |
| 79 | superoxide anion generation (GO:0042554) | 3.40712029 |
| 80 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.40010231 |
| 81 | regulation of gene silencing by miRNA (GO:0060964) | 3.40010231 |
| 82 | regulation of gene silencing by RNA (GO:0060966) | 3.40010231 |
| 83 | monocyte chemotaxis (GO:0002548) | 3.39679164 |
| 84 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.37530589 |
| 85 | signal peptide processing (GO:0006465) | 3.36453507 |
| 86 | detection of light stimulus involved in visual perception (GO:0050908) | 3.35234580 |
| 87 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.35234580 |
| 88 | regulation of mast cell degranulation (GO:0043304) | 3.34369408 |
| 89 | flavonoid metabolic process (GO:0009812) | 3.33465852 |
| 90 | cellular ketone body metabolic process (GO:0046950) | 3.32970142 |
| 91 | phagocytosis, engulfment (GO:0006911) | 3.30661089 |
| 92 | mast cell activation (GO:0045576) | 3.29219493 |
| 93 | gamma-aminobutyric acid transport (GO:0015812) | 3.29041118 |
| 94 | regulation of mononuclear cell migration (GO:0071675) | 3.28346990 |
| 95 | positive regulation of T cell migration (GO:2000406) | 3.26237255 |
| 96 | myeloid leukocyte activation (GO:0002274) | 3.25734558 |
| 97 | establishment of protein localization to Golgi (GO:0072600) | 3.25211737 |
| 98 | lymphocyte chemotaxis (GO:0048247) | 3.25019782 |
| 99 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.24288843 |
| 100 | cellular response to exogenous dsRNA (GO:0071360) | 3.23895043 |
| 101 | eosinophil migration (GO:0072677) | 3.21462767 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 3.20231252 |
| 103 | positive regulation of chemokine secretion (GO:0090197) | 3.20027820 |
| 104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.19901103 |
| 105 | positive regulation of mast cell degranulation (GO:0043306) | 3.18419922 |
| 106 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.18419922 |
| 107 | regulation of lymphocyte migration (GO:2000401) | 3.17791865 |
| 108 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.14000769 |
| 109 | negative regulation of B cell proliferation (GO:0030889) | 3.13465895 |
| 110 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.13365785 |
| 111 | NAD biosynthetic process (GO:0009435) | 3.12550293 |
| 112 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.12503703 |
| 113 | reflex (GO:0060004) | 3.11207219 |
| 114 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.11182594 |
| 115 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.09263741 |
| 116 | cardiovascular system development (GO:0072358) | 3.09157475 |
| 117 | lipoxygenase pathway (GO:0019372) | 3.07285744 |
| 118 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.05212369 |
| 119 | dendritic cell migration (GO:0036336) | 3.05126203 |
| 120 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.05086592 |
| 121 | protein K63-linked deubiquitination (GO:0070536) | 3.03860077 |
| 122 | protein K11-linked deubiquitination (GO:0035871) | 3.03563277 |
| 123 | negative regulation of granulocyte differentiation (GO:0030853) | 3.03533510 |
| 124 | negative regulation of interleukin-12 production (GO:0032695) | 3.02387374 |
| 125 | I-kappaB phosphorylation (GO:0007252) | 3.02183176 |
| 126 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.01962306 |
| 127 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.01670811 |
| 128 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.01232356 |
| 129 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.00000620 |
| 130 | defense response to protozoan (GO:0042832) | 2.99984794 |
| 131 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.98575120 |
| 132 | dendritic cell chemotaxis (GO:0002407) | 2.95723553 |
| 133 | response to muramyl dipeptide (GO:0032495) | 2.95510700 |
| 134 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.95178013 |
| 135 | B cell mediated immunity (GO:0019724) | 2.94256412 |
| 136 | ketone body metabolic process (GO:1902224) | 2.93595161 |
| 137 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.91750554 |
| 138 | negative regulation of cell killing (GO:0031342) | 2.90558262 |
| 139 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.90558262 |
| 140 | germinal center formation (GO:0002467) | 2.89681103 |
| 141 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.89507930 |
| 142 | interferon-gamma production (GO:0032609) | 2.89339235 |
| 143 | glycosphingolipid catabolic process (GO:0046479) | 2.89178884 |
| 144 | regulation of leukocyte degranulation (GO:0043300) | 2.87809586 |
| 145 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.86537368 |
| 146 | T-helper 1 type immune response (GO:0042088) | 2.85689880 |
| 147 | regulation of T cell migration (GO:2000404) | 2.84756465 |
| 148 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.84332325 |
| 149 | amine catabolic process (GO:0009310) | 2.83482197 |
| 150 | cellular biogenic amine catabolic process (GO:0042402) | 2.83482197 |
| 151 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82655082 |
| 152 | thyroid hormone metabolic process (GO:0042403) | 2.82185194 |
| 153 | leukocyte degranulation (GO:0043299) | 2.81033695 |
| 154 | myeloid dendritic cell activation (GO:0001773) | 2.80455340 |
| 155 | behavioral response to ethanol (GO:0048149) | 2.80243892 |
| 156 | leukocyte aggregation (GO:0070486) | 2.78749408 |
| 157 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.77725389 |
| 158 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75672687 |
| 159 | lipid translocation (GO:0034204) | 2.75385809 |
| 160 | phospholipid translocation (GO:0045332) | 2.75385809 |
| 161 | pericardium development (GO:0060039) | 2.74530156 |
| 162 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.72070210 |
| 163 | negative regulation of protein localization to cell surface (GO:2000009) | 2.70524749 |
| 164 | membrane depolarization during action potential (GO:0086010) | 2.69237479 |
| 165 | regulation of action potential (GO:0098900) | 2.67860936 |
| 166 | cellular response to ethanol (GO:0071361) | 2.67210648 |
| 167 | protein targeting to vacuole (GO:0006623) | 2.66956794 |
| 168 | protein targeting to lysosome (GO:0006622) | 2.66956794 |
| 169 | establishment of protein localization to vacuole (GO:0072666) | 2.66956794 |
| 170 | benzene-containing compound metabolic process (GO:0042537) | 2.64945526 |
| 171 | cAMP catabolic process (GO:0006198) | 2.63554568 |
| 172 | cellular response to ATP (GO:0071318) | 2.61385912 |
| 173 | cornea development in camera-type eye (GO:0061303) | 2.61189797 |
| 174 | kidney morphogenesis (GO:0060993) | 2.57285283 |
| 175 | rRNA catabolic process (GO:0016075) | 2.56625441 |
| 176 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.54569545 |
| 177 | piRNA metabolic process (GO:0034587) | 2.53647469 |
| 178 | photoreceptor cell maintenance (GO:0045494) | 2.53472417 |
| 179 | spinal cord motor neuron differentiation (GO:0021522) | 2.52346032 |
| 180 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.51924023 |
| 181 | aromatic amino acid family catabolic process (GO:0009074) | 2.47955028 |
| 182 | regulation of mesoderm development (GO:2000380) | 2.47280696 |
| 183 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.45199026 |
| 184 | endocardial cushion development (GO:0003197) | 2.45149141 |
| 185 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.44923110 |
| 186 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.44813268 |
| 187 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.44714320 |
| 188 | endoderm formation (GO:0001706) | 2.41439380 |
| 189 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.40358764 |
| 190 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.40109669 |
| 191 | cilium organization (GO:0044782) | 2.38536707 |
| 192 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.37963138 |
| 193 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.37963138 |
| 194 | proline transport (GO:0015824) | 2.37608017 |
| 195 | DNA demethylation (GO:0080111) | 2.37462470 |
| 196 | cyclic nucleotide catabolic process (GO:0009214) | 2.36731246 |
| 197 | DNA deamination (GO:0045006) | 2.36278195 |
| 198 | positive regulation of action potential (GO:0045760) | 2.36132245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.57513926 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.71599599 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.20214512 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.73395110 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.69302307 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.39615088 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.66585171 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.51714763 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.50544091 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.46732207 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.41689356 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.33742543 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.32503232 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.23945180 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17861235 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 3.02120830 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.69609402 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.63761273 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58915905 |
| 20 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49643661 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.39738015 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.31980003 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.28561097 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.26129655 |
| 25 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.22077583 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20148399 |
| 27 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.06372727 |
| 28 | EWS_26573619_Chip-Seq_HEK293_Human | 2.06002367 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.05939551 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.04901372 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.04410908 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.03909282 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00788892 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.00700031 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.99627486 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.99527801 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.96953572 |
| 38 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.93605565 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92563266 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.90984776 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90374045 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88854799 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86455470 |
| 44 | STAT3_23295773_ChIP-Seq_U87_Human | 1.85693023 |
| 45 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.83931883 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82574918 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.78671648 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78171806 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.75103213 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71830313 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71574224 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69492104 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68930528 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66874331 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.65826669 |
| 56 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64612398 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.64520695 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63195266 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.62930061 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58812291 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58244318 |
| 62 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.58234981 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.57013910 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55712593 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.54795877 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.53062933 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53042707 |
| 68 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.51606968 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51606968 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50299960 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48878594 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48117936 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46931182 |
| 74 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46889816 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45075502 |
| 76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.43977144 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.43326476 |
| 78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.38844182 |
| 79 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.38844182 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38816391 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38763994 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36947954 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36789451 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33067379 |
| 85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31875601 |
| 86 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.31825273 |
| 87 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.31272508 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31092709 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29914429 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29839106 |
| 91 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.29049374 |
| 92 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.28003684 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27250189 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.26771882 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26049660 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26029261 |
| 97 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25487489 |
| 98 | MYB_26560356_Chip-Seq_TH1_Human | 1.25219870 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24385530 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23563595 |
| 101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22705904 |
| 102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21720862 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21070410 |
| 104 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.20359938 |
| 105 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20033635 |
| 106 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19436511 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19144560 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.17459234 |
| 109 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16515858 |
| 110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13813632 |
| 111 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13551754 |
| 112 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13027351 |
| 113 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13027351 |
| 114 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12364282 |
| 115 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12192249 |
| 116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12130831 |
| 117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11783700 |
| 118 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11602670 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09661425 |
| 120 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08955040 |
| 121 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08955040 |
| 122 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08531446 |
| 123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08427366 |
| 124 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08013177 |
| 125 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07419707 |
| 126 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07335003 |
| 127 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.07061948 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06983057 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06895792 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05869328 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05708969 |
| 132 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05655268 |
| 133 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05642909 |
| 134 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.05468821 |
| 135 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03480470 |
| 136 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03278000 |
| 137 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03184214 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03124181 |
| 139 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02526939 |
| 140 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01651467 |
| 141 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01431904 |
| 142 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99900618 |
| 143 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99327788 |
| 144 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98787366 |
| 145 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98452679 |
| 146 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98427273 |
| 147 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97915582 |
| 148 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97314934 |
| 149 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96956610 |
| 150 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92408231 |
| 151 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91020060 |
| 152 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85911009 |
| 153 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84321750 |
| 154 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83149511 |
| 155 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83031400 |
| 156 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83007229 |
| 157 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82792628 |
| 158 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81404941 |
| 159 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80725370 |
| 160 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.79892984 |
| 161 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.78508305 |
| 162 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.78481419 |
| 163 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.76604050 |
| 164 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76059393 |
| 165 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.75258218 |
| 166 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.75030050 |
| 167 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.73216791 |
| 168 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.72463830 |
| 169 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.72255891 |
| 170 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70959466 |
| 171 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69779359 |
| 172 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69779359 |
| 173 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.69763630 |
| 174 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.69673356 |
| 175 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69328536 |
| 176 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.68967820 |
| 177 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.68712520 |
| 178 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.68353553 |
| 179 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.67817871 |
| 180 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.66376013 |
| 181 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.66347315 |
| 182 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.65871099 |
| 183 | UTX_26944678_Chip-Seq_JUKART_Human | 0.65866094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.13375392 |
| 2 | MP0003436_decreased_susceptibility_to | 3.88551449 |
| 3 | MP0003195_calcinosis | 3.82057735 |
| 4 | * MP0002148_abnormal_hypersensitivity_rea | 3.70416625 |
| 5 | MP0006082_CNS_inflammation | 3.53162787 |
| 6 | MP0003303_peritoneal_inflammation | 3.38164317 |
| 7 | MP0002419_abnormal_innate_immunity | 3.36032659 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.26823510 |
| 9 | MP0009785_altered_susceptibility_to | 3.22820991 |
| 10 | MP0003646_muscle_fatigue | 3.20100593 |
| 11 | MP0005671_abnormal_response_to | 3.17298408 |
| 12 | MP0005387_immune_system_phenotype | 3.03142677 |
| 13 | MP0001790_abnormal_immune_system | 3.03142677 |
| 14 | MP0005025_abnormal_response_to | 2.92342306 |
| 15 | MP0003724_increased_susceptibility_to | 2.87993749 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.81436667 |
| 17 | MP0008057_abnormal_DNA_replication | 2.79220650 |
| 18 | MP0009046_muscle_twitch | 2.75150032 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.74086477 |
| 20 | MP0001800_abnormal_humoral_immune | 2.65557175 |
| 21 | MP0004043_abnormal_pH_regulation | 2.61281661 |
| 22 | MP0002723_abnormal_immune_serum | 2.58029014 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.55957202 |
| 24 | MP0008877_abnormal_DNA_methylation | 2.51299396 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 2.46184315 |
| 26 | MP0004510_myositis | 2.43861093 |
| 27 | MP0000685_abnormal_immune_system | 2.42308624 |
| 28 | MP0001819_abnormal_immune_cell | 2.38852943 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.36541065 |
| 30 | MP0000427_abnormal_hair_cycle | 2.32638416 |
| 31 | MP0001968_abnormal_touch/_nociception | 2.30621492 |
| 32 | MP0001501_abnormal_sleep_pattern | 2.26772948 |
| 33 | MP0005464_abnormal_platelet_physiology | 2.16194562 |
| 34 | MP0001533_abnormal_skeleton_physiology | 2.06359347 |
| 35 | MP0000343_altered_response_to | 2.05234934 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 2.04536143 |
| 37 | MP0008961_abnormal_basal_metabolism | 2.04117417 |
| 38 | MP0009745_abnormal_behavioral_response | 2.02441307 |
| 39 | MP0005310_abnormal_salivary_gland | 1.95038070 |
| 40 | MP0002102_abnormal_ear_morphology | 1.91422093 |
| 41 | MP0004142_abnormal_muscle_tone | 1.91346904 |
| 42 | MP0003787_abnormal_imprinting | 1.88588518 |
| 43 | * MP0002405_respiratory_system_inflammati | 1.87118768 |
| 44 | MP0002736_abnormal_nociception_after | 1.84740480 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.82801331 |
| 46 | MP0003690_abnormal_glial_cell | 1.82795421 |
| 47 | MP0001853_heart_inflammation | 1.79924142 |
| 48 | MP0008872_abnormal_physiological_respon | 1.72638139 |
| 49 | MP0003890_abnormal_embryonic-extraembry | 1.71461579 |
| 50 | MP0000383_abnormal_hair_follicle | 1.70987304 |
| 51 | MP0003075_altered_response_to | 1.70144283 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.68163557 |
| 53 | MP0004130_abnormal_muscle_cell | 1.67920574 |
| 54 | MP0009764_decreased_sensitivity_to | 1.66804138 |
| 55 | MP0003136_yellow_coat_color | 1.65470628 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.64860222 |
| 57 | MP0000716_abnormal_immune_system | 1.62822423 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.62379207 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.59947309 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.59459029 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.57026936 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.57001917 |
| 63 | MP0000569_abnormal_digit_pigmentation | 1.56586034 |
| 64 | MP0008469_abnormal_protein_level | 1.56381159 |
| 65 | MP0002272_abnormal_nervous_system | 1.56075246 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 1.55618726 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.54946244 |
| 68 | MP0002876_abnormal_thyroid_physiology | 1.54843147 |
| 69 | MP0003448_altered_tumor_morphology | 1.53545245 |
| 70 | MP0002064_seizures | 1.51877015 |
| 71 | MP0003300_gastrointestinal_ulcer | 1.51063849 |
| 72 | MP0001486_abnormal_startle_reflex | 1.48259624 |
| 73 | MP0005253_abnormal_eye_physiology | 1.47234428 |
| 74 | MP0002735_abnormal_chemical_nociception | 1.46772564 |
| 75 | MP0002398_abnormal_bone_marrow | 1.46508984 |
| 76 | MP0001986_abnormal_taste_sensitivity | 1.44010149 |
| 77 | MP0001485_abnormal_pinna_reflex | 1.42958844 |
| 78 | MP0005386_behavior/neurological_phenoty | 1.40881367 |
| 79 | MP0004924_abnormal_behavior | 1.40881367 |
| 80 | MP0005174_abnormal_tail_pigmentation | 1.39684270 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39574219 |
| 82 | MP0002006_tumorigenesis | 1.35819106 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.35317475 |
| 84 | MP0004145_abnormal_muscle_electrophysio | 1.32306047 |
| 85 | MP0005166_decreased_susceptibility_to | 1.32170345 |
| 86 | MP0006072_abnormal_retinal_apoptosis | 1.30950980 |
| 87 | MP0002733_abnormal_thermal_nociception | 1.28945309 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 1.28186446 |
| 89 | MP0000015_abnormal_ear_pigmentation | 1.27641054 |
| 90 | MP0002067_abnormal_sensory_capabilities | 1.27354627 |
| 91 | MP0000689_abnormal_spleen_morphology | 1.26567771 |
| 92 | MP0002429_abnormal_blood_cell | 1.25173145 |
| 93 | MP0001970_abnormal_pain_threshold | 1.24978158 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 1.24827874 |
| 95 | MP0003828_pulmonary_edema | 1.24580789 |
| 96 | MP0004947_skin_inflammation | 1.24250630 |
| 97 | MP0003252_abnormal_bile_duct | 1.23245239 |
| 98 | MP0002933_joint_inflammation | 1.22243008 |
| 99 | MP0004147_increased_porphyrin_level | 1.22065681 |
| 100 | MP0004133_heterotaxia | 1.21434772 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 1.21213531 |
| 102 | MP0005266_abnormal_metabolism | 1.18705881 |
| 103 | MP0000230_abnormal_systemic_arterial | 1.16436514 |
| 104 | MP0002396_abnormal_hematopoietic_system | 1.16023398 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 1.14017674 |
| 106 | MP0002722_abnormal_immune_system | 1.13082949 |
| 107 | MP0002653_abnormal_ependyma_morphology | 1.11501301 |
| 108 | MP0003763_abnormal_thymus_physiology | 1.11112405 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 1.10828700 |
| 110 | MP0003635_abnormal_synaptic_transmissio | 1.10536013 |
| 111 | MP0000858_altered_metastatic_potential | 1.10054093 |
| 112 | MP0008260_abnormal_autophagy | 1.09736690 |
| 113 | MP0003880_abnormal_central_pattern | 1.07603091 |
| 114 | MP0001851_eye_inflammation | 1.07219585 |
| 115 | MP0004885_abnormal_endolymph | 1.07099456 |
| 116 | MP0005085_abnormal_gallbladder_physiolo | 1.06598830 |
| 117 | MP0004215_abnormal_myocardial_fiber | 1.04647475 |
| 118 | MP0005448_abnormal_energy_balance | 1.04540073 |
| 119 | MP0000490_abnormal_crypts_of | 1.02798988 |
| 120 | MP0001873_stomach_inflammation | 1.02460579 |
| 121 | MP0005390_skeleton_phenotype | 1.02382668 |
| 122 | MP0000604_amyloidosis | 1.02279719 |
| 123 | MP0002557_abnormal_social/conspecific_i | 1.01374712 |
| 124 | MP0002063_abnormal_learning/memory/cond | 0.99668761 |
| 125 | MP0000538_abnormal_urinary_bladder | 0.96062758 |
| 126 | MP0002009_preneoplasia | 0.95649098 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.95089383 |
| 128 | MP0006276_abnormal_autonomic_nervous | 0.94636929 |
| 129 | MP0004742_abnormal_vestibular_system | 0.93884167 |
| 130 | MP0005167_abnormal_blood-brain_barrier | 0.89886889 |
| 131 | MP0001324_abnormal_eye_pigmentation | 0.88631675 |
| 132 | MP0003866_abnormal_defecation | 0.88319363 |
| 133 | MP0005195_abnormal_posterior_eye | 0.87352319 |
| 134 | MP0002938_white_spotting | 0.87144719 |
| 135 | MP0002734_abnormal_mechanical_nocicepti | 0.86833387 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.86527819 |
| 137 | MP0002132_abnormal_respiratory_system | 0.86000652 |
| 138 | MP0005389_reproductive_system_phenotype | 0.85981301 |
| 139 | MP0010329_abnormal_lipoprotein_level | 0.84594761 |
| 140 | MP0000470_abnormal_stomach_morphology | 0.84567248 |
| 141 | MP0009763_increased_sensitivity_to | 0.83603720 |
| 142 | * MP0000249_abnormal_blood_vessel | 0.82057487 |
| 143 | MP0001542_abnormal_bone_strength | 0.82030485 |
| 144 | MP0009840_abnormal_foam_cell | 0.81872799 |
| 145 | MP0003633_abnormal_nervous_system | 0.81615834 |
| 146 | MP0002168_other_aberrant_phenotype | 0.81585327 |
| 147 | MP0006292_abnormal_olfactory_placode | 0.81261477 |
| 148 | MP0005164_abnormal_response_to | 0.80711056 |
| 149 | MP0001545_abnormal_hematopoietic_system | 0.79347216 |
| 150 | MP0005397_hematopoietic_system_phenotyp | 0.79347216 |
| 151 | MP0000371_diluted_coat_color | 0.78596218 |
| 152 | MP0004883_abnormal_blood_vessel | 0.76923963 |
| 153 | MP0003959_abnormal_lean_body | 0.76830190 |
| 154 | MP0002160_abnormal_reproductive_system | 0.75763191 |
| 155 | MP0002229_neurodegeneration | 0.75086979 |
| 156 | MP0005076_abnormal_cell_differentiation | 0.74876480 |
| 157 | MP0002928_abnormal_bile_duct | 0.72478102 |
| 158 | MP0003795_abnormal_bone_structure | 0.72461750 |
| 159 | MP0001664_abnormal_digestion | 0.71407472 |
| 160 | MP0008775_abnormal_heart_ventricle | 0.70361060 |
| 161 | MP0003119_abnormal_digestive_system | 0.68504289 |
| 162 | MP0005165_increased_susceptibility_to | 0.68160774 |
| 163 | MP0003631_nervous_system_phenotype | 0.67802644 |
| 164 | MP0002638_abnormal_pupillary_reflex | 0.67676641 |
| 165 | MP0001919_abnormal_reproductive_system | 0.66673789 |
| 166 | MP0010678_abnormal_skin_adnexa | 0.66615541 |
| 167 | MP0003566_abnormal_cell_adhesion | 0.66599296 |
| 168 | MP0000767_abnormal_smooth_muscle | 0.65714822 |
| 169 | MP0009278_abnormal_bone_marrow | 0.65621456 |
| 170 | MP0005171_absent_coat_pigmentation | 0.65241917 |
| 171 | MP0002751_abnormal_autonomic_nervous | 0.64147518 |
| 172 | MP0000703_abnormal_thymus_morphology | 0.63852854 |
| 173 | MP0001663_abnormal_digestive_system | 0.61721177 |
| 174 | MP0002332_abnormal_exercise_endurance | 0.60804293 |
| 175 | MP0003045_fibrosis | 0.60214883 |
| 176 | MP0001915_intracranial_hemorrhage | 0.58233271 |
| 177 | MP0002254_reproductive_system_inflammat | 0.56482366 |
| 178 | MP0000681_abnormal_thyroid_gland | 0.56213991 |
| 179 | MP0005197_abnormal_uvea_morphology | 0.54280708 |
| 180 | MP0002136_abnormal_kidney_physiology | 0.53289903 |
| 181 | MP0002095_abnormal_skin_pigmentation | 0.50802335 |
| 182 | MP0003279_aneurysm | 0.49560474 |
| 183 | MP0008873_increased_physiological_sensi | 0.46627643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.70083368 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.16882072 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.13801306 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.94842827 |
| 5 | Optic neuritis (HP:0100653) | 5.58300686 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.58300686 |
| 7 | Myositis (HP:0100614) | 5.51226117 |
| 8 | Orchitis (HP:0100796) | 5.27778276 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.03789166 |
| 10 | Pancreatic cysts (HP:0001737) | 5.00995043 |
| 11 | Genetic anticipation (HP:0003743) | 4.73074743 |
| 12 | Hyperventilation (HP:0002883) | 4.61788694 |
| 13 | Glomerulonephritis (HP:0000099) | 4.55171385 |
| 14 | Pancreatic fibrosis (HP:0100732) | 4.36073080 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.21392659 |
| 16 | Obstructive lung disease (HP:0006536) | 4.21392659 |
| 17 | Abnormality of macrophages (HP:0004311) | 4.10548451 |
| 18 | True hermaphroditism (HP:0010459) | 4.08452489 |
| 19 | Protruding tongue (HP:0010808) | 4.07864509 |
| 20 | Congenital stationary night blindness (HP:0007642) | 4.05551747 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.03023784 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.97121349 |
| 23 | Recurrent skin infections (HP:0001581) | 3.95370970 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.95216355 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.95216355 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 3.95216355 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.94102497 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 3.85962742 |
| 29 | Disinhibition (HP:0000734) | 3.74855692 |
| 30 | Abnormality of midbrain morphology (HP:0002418) | 3.71053228 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 3.71053228 |
| 32 | Recurrent fungal infections (HP:0002841) | 3.67852244 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 3.66851989 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 3.62306381 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.61502626 |
| 36 | Clumsiness (HP:0002312) | 3.56567890 |
| 37 | Keratoconjunctivitis sicca (HP:0001097) | 3.53429534 |
| 38 | Gingivitis (HP:0000230) | 3.52716022 |
| 39 | Nephronophthisis (HP:0000090) | 3.40530469 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.31489231 |
| 41 | Abnormality of the renal cortex (HP:0011035) | 3.31235880 |
| 42 | Prostate neoplasm (HP:0100787) | 3.27528191 |
| 43 | Agnosia (HP:0010524) | 3.24765072 |
| 44 | Pulmonary infiltrates (HP:0002113) | 3.22282424 |
| 45 | Inability to walk (HP:0002540) | 3.19973721 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 3.19750439 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.19750439 |
| 48 | Arterial thrombosis (HP:0004420) | 3.18924514 |
| 49 | Keratoconjunctivitis (HP:0001096) | 3.18088098 |
| 50 | Cystic liver disease (HP:0006706) | 3.17376147 |
| 51 | Tubular atrophy (HP:0000092) | 3.16304567 |
| 52 | Meningitis (HP:0001287) | 3.15311867 |
| 53 | Vasculitis (HP:0002633) | 3.14461649 |
| 54 | Stomatitis (HP:0010280) | 3.12217094 |
| 55 | Fair hair (HP:0002286) | 3.11027741 |
| 56 | Abnormality of the renal medulla (HP:0100957) | 3.10903765 |
| 57 | Progressive inability to walk (HP:0002505) | 3.09204475 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.09186588 |
| 59 | Attenuation of retinal blood vessels (HP:0007843) | 3.08037260 |
| 60 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.05273212 |
| 61 | Abnormality of alanine metabolism (HP:0010916) | 3.02319592 |
| 62 | Hyperalaninemia (HP:0003348) | 3.02319592 |
| 63 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.02319592 |
| 64 | Hemoptysis (HP:0002105) | 2.94562698 |
| 65 | Birth length less than 3rd percentile (HP:0003561) | 2.90498955 |
| 66 | Large for gestational age (HP:0001520) | 2.89885521 |
| 67 | Abnormality of complement system (HP:0005339) | 2.88914153 |
| 68 | Axonal loss (HP:0003447) | 2.88230777 |
| 69 | Medial flaring of the eyebrow (HP:0010747) | 2.86688717 |
| 70 | Periodontitis (HP:0000704) | 2.86176251 |
| 71 | Furrowed tongue (HP:0000221) | 2.79844619 |
| 72 | Chronic hepatic failure (HP:0100626) | 2.77887417 |
| 73 | Pustule (HP:0200039) | 2.77774195 |
| 74 | Thick nail (HP:0001805) | 2.76210198 |
| 75 | Complement deficiency (HP:0004431) | 2.75962559 |
| 76 | Recurrent viral infections (HP:0004429) | 2.75225477 |
| 77 | Basal ganglia calcification (HP:0002135) | 2.74688670 |
| 78 | Nephritis (HP:0000123) | 2.74242939 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.73771638 |
| 80 | Patellar aplasia (HP:0006443) | 2.66795853 |
| 81 | Febrile seizures (HP:0002373) | 2.64700590 |
| 82 | Abolished electroretinogram (ERG) (HP:0000550) | 2.64541999 |
| 83 | Recurrent pneumonia (HP:0006532) | 2.63456484 |
| 84 | IgM deficiency (HP:0002850) | 2.62905056 |
| 85 | Type II lissencephaly (HP:0007260) | 2.62342847 |
| 86 | Abnormality of the prostate (HP:0008775) | 2.60986193 |
| 87 | Decreased circulating renin level (HP:0003351) | 2.56735754 |
| 88 | Dysostosis multiplex (HP:0000943) | 2.54975388 |
| 89 | Chronic diarrhea (HP:0002028) | 2.53793218 |
| 90 | Absent/shortened dynein arms (HP:0200106) | 2.52440585 |
| 91 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.52440585 |
| 92 | Generalized hypopigmentation of hair (HP:0011358) | 2.47207201 |
| 93 | Stomach cancer (HP:0012126) | 2.47149152 |
| 94 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.45505174 |
| 95 | Gangrene (HP:0100758) | 2.44511547 |
| 96 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.42530837 |
| 97 | Osteomyelitis (HP:0002754) | 2.41909114 |
| 98 | Broad-based gait (HP:0002136) | 2.40183993 |
| 99 | Hematochezia (HP:0002573) | 2.39817675 |
| 100 | Congenital, generalized hypertrichosis (HP:0004540) | 2.39668543 |
| 101 | Glomerulopathy (HP:0100820) | 2.39664640 |
| 102 | Joint hemorrhage (HP:0005261) | 2.36794628 |
| 103 | Gait imbalance (HP:0002141) | 2.33685226 |
| 104 | Inflammation of the large intestine (HP:0002037) | 2.32246010 |
| 105 | Encephalitis (HP:0002383) | 2.31342009 |
| 106 | Urticaria (HP:0001025) | 2.31196630 |
| 107 | Polydipsia (HP:0001959) | 2.30406948 |
| 108 | Abnormal drinking behavior (HP:0030082) | 2.30406948 |
| 109 | Autoimmune thrombocytopenia (HP:0001973) | 2.30307265 |
| 110 | Hypoplastic ischia (HP:0003175) | 2.29409137 |
| 111 | Congenital hepatic fibrosis (HP:0002612) | 2.29323611 |
| 112 | Widely spaced teeth (HP:0000687) | 2.28726688 |
| 113 | Hepatosplenomegaly (HP:0001433) | 2.27708365 |
| 114 | Lissencephaly (HP:0001339) | 2.27245449 |
| 115 | Absent speech (HP:0001344) | 2.27228278 |
| 116 | Cellulitis (HP:0100658) | 2.26365274 |
| 117 | Congenital primary aphakia (HP:0007707) | 2.26058105 |
| 118 | Pulmonary embolism (HP:0002204) | 2.23551975 |
| 119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.23402039 |
| 120 | Anorexia (HP:0002039) | 2.22869175 |
| 121 | Recurrent lower respiratory tract infections (HP:0002783) | 2.21684437 |
| 122 | Sclerocornea (HP:0000647) | 2.21213344 |
| 123 | Abnormality of the pleura (HP:0002103) | 2.20113277 |
| 124 | Gingival bleeding (HP:0000225) | 2.19148895 |
| 125 | Congenital sensorineural hearing impairment (HP:0008527) | 2.18770689 |
| 126 | Myocardial infarction (HP:0001658) | 2.16286067 |
| 127 | Bone pain (HP:0002653) | 2.16130303 |
| 128 | Pathologic fracture (HP:0002756) | 2.14669224 |
| 129 | Chorioretinal atrophy (HP:0000533) | 2.12921701 |
| 130 | Inappropriate behavior (HP:0000719) | 2.10528462 |
| 131 | Cheilitis (HP:0100825) | 2.09844222 |
| 132 | Petechiae (HP:0000967) | 2.09812802 |
| 133 | Osteolytic defects of the hand bones (HP:0009699) | 2.09030246 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09030246 |
| 135 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07805072 |
| 136 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05888937 |
| 137 | Anencephaly (HP:0002323) | 2.03968179 |
| 138 | Abnormality of the pericardium (HP:0001697) | 2.03263559 |
| 139 | Increased IgM level (HP:0003496) | 2.03041982 |
| 140 | Abnormality of the ischium (HP:0003174) | 2.01378990 |
| 141 | Cerebellar dysplasia (HP:0007033) | 2.01018612 |
| 142 | Gastrointestinal inflammation (HP:0004386) | 2.01005518 |
| 143 | Abnormality of T cell physiology (HP:0011840) | 2.00600924 |
| 144 | Leukocytosis (HP:0001974) | 2.00102577 |
| 145 | Prolonged bleeding time (HP:0003010) | 1.99716925 |
| 146 | Male pseudohermaphroditism (HP:0000037) | 1.98431435 |
| 147 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.96602597 |
| 148 | Spinal cord lesions (HP:0100561) | 1.96524401 |
| 149 | Syringomyelia (HP:0003396) | 1.96524401 |
| 150 | Upper motor neuron abnormality (HP:0002127) | 1.96449796 |
| 151 | Increased corneal curvature (HP:0100692) | 1.96380845 |
| 152 | Keratoconus (HP:0000563) | 1.96380845 |
| 153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96140448 |
| 154 | Mucopolysacchariduria (HP:0008155) | 1.96140448 |
| 155 | Macroglossia (HP:0000158) | 1.95079679 |
| 156 | Absent frontal sinuses (HP:0002688) | 1.94696536 |
| 157 | Abnormality of the lumbar spine (HP:0100712) | 1.94647942 |
| 158 | Genital tract atresia (HP:0001827) | 1.94617525 |
| 159 | Small hand (HP:0200055) | 1.94311856 |
| 160 | Abnormality of T cells (HP:0002843) | 1.93159337 |
| 161 | Abnormality of secondary sexual hair (HP:0009888) | 1.92840720 |
| 162 | Abnormality of the axillary hair (HP:0100134) | 1.92840720 |
| 163 | Dialeptic seizures (HP:0011146) | 1.91196646 |
| 164 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90777840 |
| 165 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90777840 |
| 166 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90777840 |
| 167 | Abnormal biliary tract physiology (HP:0012439) | 1.90743106 |
| 168 | Bile duct proliferation (HP:0001408) | 1.90743106 |
| 169 | Renal cortical cysts (HP:0000803) | 1.90681639 |
| 170 | Chest pain (HP:0100749) | 1.89771023 |
| 171 | Arthralgia (HP:0002829) | 1.89721671 |
| 172 | Colitis (HP:0002583) | 1.89602657 |
| 173 | Abnormality of T cell number (HP:0011839) | 1.89386370 |
| 174 | Hypoplastic labia majora (HP:0000059) | 1.88481162 |
| 175 | Decreased central vision (HP:0007663) | 1.88251405 |
| 176 | Vaginal atresia (HP:0000148) | 1.88052514 |
| 177 | Poor coordination (HP:0002370) | 1.87994896 |
| 178 | J-shaped sella turcica (HP:0002680) | 1.87912082 |
| 179 | Abnormality of the pons (HP:0007361) | 1.85560462 |
| 180 | Hypoplasia of the pons (HP:0012110) | 1.84554777 |
| 181 | Pendular nystagmus (HP:0012043) | 1.84196924 |
| 182 | Focal seizures (HP:0007359) | 1.81727709 |
| 183 | Partial agenesis of the corpus callosum (HP:0001338) | 1.81694735 |
| 184 | Focal motor seizures (HP:0011153) | 1.80540927 |
| 185 | Abnormality of the labia majora (HP:0012881) | 1.80464905 |
| 186 | Preaxial foot polydactyly (HP:0001841) | 1.80190674 |
| 187 | Short foot (HP:0001773) | 1.78285699 |
| 188 | Postaxial foot polydactyly (HP:0001830) | 1.75844884 |
| 189 | Drooling (HP:0002307) | 1.73611434 |
| 190 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.72315595 |
| 191 | Preaxial hand polydactyly (HP:0001177) | 1.72038935 |
| 192 | Prominent supraorbital ridges (HP:0000336) | 1.71601102 |
| 193 | Concave nail (HP:0001598) | 1.71081775 |
| 194 | Hemiparesis (HP:0001269) | 1.69654633 |
| 195 | Polyuria (HP:0000103) | 1.67802152 |
| 196 | Dandy-Walker malformation (HP:0001305) | 1.67729743 |
| 197 | Bulbous nose (HP:0000414) | 1.67213628 |
| 198 | Amelogenesis imperfecta (HP:0000705) | 1.64652603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 9.37327921 |
| 2 | BLK | 5.85785676 |
| 3 | ACVR1B | 4.64433238 |
| 4 | TXK | 4.23279429 |
| 5 | MAP3K14 | 4.07041852 |
| 6 | IRAK3 | 3.40888795 |
| 7 | IRAK4 | 3.33416172 |
| 8 | TGFBR2 | 3.16245572 |
| 9 | GRK7 | 2.71560573 |
| 10 | MAP4K1 | 2.61735621 |
| 11 | RIPK4 | 2.58874413 |
| 12 | TYK2 | 2.46857746 |
| 13 | KIT | 2.15791074 |
| 14 | CSF1R | 2.02796214 |
| 15 | AKT3 | 2.00447585 |
| 16 | NEK9 | 1.91747814 |
| 17 | TBK1 | 1.90632281 |
| 18 | INSRR | 1.87788350 |
| 19 | ZAP70 | 1.82091935 |
| 20 | JAK3 | 1.79065688 |
| 21 | JAK1 | 1.78707774 |
| 22 | SIK3 | 1.77850771 |
| 23 | IKBKB | 1.67083837 |
| 24 | MAP3K13 | 1.64566458 |
| 25 | MAPK13 | 1.62868444 |
| 26 | TGFBR1 | 1.59800398 |
| 27 | TEC | 1.58027593 |
| 28 | TLK1 | 1.56948954 |
| 29 | WNK3 | 1.56052511 |
| 30 | OXSR1 | 1.54809185 |
| 31 | ADRBK1 | 1.52917361 |
| 32 | IKBKE | 1.51173889 |
| 33 | SYK | 1.49823782 |
| 34 | CSK | 1.47509307 |
| 35 | LYN | 1.40439903 |
| 36 | BTK | 1.38863881 |
| 37 | CAMKK2 | 1.38134726 |
| 38 | FGR | 1.34010737 |
| 39 | MST4 | 1.32469503 |
| 40 | WNK4 | 1.31938920 |
| 41 | TAOK3 | 1.29942734 |
| 42 | BMPR2 | 1.29381650 |
| 43 | ITK | 1.26540207 |
| 44 | HCK | 1.25809279 |
| 45 | MAP3K4 | 1.24298759 |
| 46 | DAPK2 | 1.24022176 |
| 47 | STK10 | 1.23303237 |
| 48 | MAP3K12 | 1.21557976 |
| 49 | LCK | 1.20425738 |
| 50 | CLK1 | 1.17383640 |
| 51 | MAP4K2 | 1.15330960 |
| 52 | NTRK3 | 1.14543651 |
| 53 | ADRBK2 | 1.11876806 |
| 54 | EIF2AK2 | 1.10512485 |
| 55 | STK38L | 1.10038320 |
| 56 | MATK | 1.09475548 |
| 57 | PINK1 | 1.09383529 |
| 58 | JAK2 | 1.05003808 |
| 59 | NUAK1 | 1.03690665 |
| 60 | PBK | 1.01280206 |
| 61 | PIM2 | 1.01230785 |
| 62 | FES | 0.99821013 |
| 63 | FGFR3 | 0.98814988 |
| 64 | STK39 | 0.95571568 |
| 65 | PTK2B | 0.94990282 |
| 66 | EPHB1 | 0.94569815 |
| 67 | TNIK | 0.93741952 |
| 68 | BRSK2 | 0.89865270 |
| 69 | YES1 | 0.88380670 |
| 70 | PIK3CA | 0.88282433 |
| 71 | CHUK | 0.85620458 |
| 72 | PNCK | 0.84498339 |
| 73 | PIM1 | 0.79273138 |
| 74 | SIK2 | 0.78644458 |
| 75 | MOS | 0.77893564 |
| 76 | PAK3 | 0.77160078 |
| 77 | CAMK1G | 0.75221177 |
| 78 | MELK | 0.73695341 |
| 79 | PRKAA2 | 0.68139882 |
| 80 | CAMK1D | 0.67917235 |
| 81 | MAPKAPK3 | 0.67420112 |
| 82 | MARK3 | 0.67069369 |
| 83 | MKNK1 | 0.66578478 |
| 84 | PAK4 | 0.66390414 |
| 85 | PRKCG | 0.65577523 |
| 86 | ERBB3 | 0.65062376 |
| 87 | PRPF4B | 0.65034960 |
| 88 | EPHA3 | 0.64260281 |
| 89 | IRAK1 | 0.63487028 |
| 90 | CDK19 | 0.62567006 |
| 91 | NLK | 0.62018772 |
| 92 | MAP3K7 | 0.61729757 |
| 93 | TRPM7 | 0.61384178 |
| 94 | STK11 | 0.59888473 |
| 95 | MAP2K3 | 0.59424783 |
| 96 | PRKCD | 0.58360297 |
| 97 | PRKCQ | 0.58191407 |
| 98 | NEK2 | 0.57473777 |
| 99 | RIPK1 | 0.56294955 |
| 100 | STK24 | 0.55265949 |
| 101 | LATS1 | 0.52413176 |
| 102 | TIE1 | 0.51879275 |
| 103 | IRAK2 | 0.51122458 |
| 104 | STK4 | 0.50544455 |
| 105 | MAP2K1 | 0.49359926 |
| 106 | BRD4 | 0.47261670 |
| 107 | ABL1 | 0.46443090 |
| 108 | CAMK2A | 0.46387043 |
| 109 | MAPKAPK2 | 0.45595041 |
| 110 | CDK6 | 0.44462240 |
| 111 | CAMK1 | 0.44065980 |
| 112 | ZAK | 0.44039867 |
| 113 | MAP2K6 | 0.42796669 |
| 114 | MARK1 | 0.42129562 |
| 115 | FGFR2 | 0.42106980 |
| 116 | ERBB2 | 0.41483834 |
| 117 | BMPR1B | 0.40591995 |
| 118 | PDK1 | 0.40319179 |
| 119 | OBSCN | 0.39761810 |
| 120 | FYN | 0.39628438 |
| 121 | RPS6KC1 | 0.38957828 |
| 122 | RPS6KL1 | 0.38957828 |
| 123 | MAP2K7 | 0.38670411 |
| 124 | PRKAA1 | 0.38349864 |
| 125 | IGF1R | 0.38308159 |
| 126 | CASK | 0.38256664 |
| 127 | WNK1 | 0.37787041 |
| 128 | CAMKK1 | 0.37429387 |
| 129 | FLT3 | 0.37202146 |
| 130 | STK38 | 0.37126030 |
| 131 | RPS6KA6 | 0.36828285 |
| 132 | GRK1 | 0.34497199 |
| 133 | SGK494 | 0.34466101 |
| 134 | SGK223 | 0.34466101 |
| 135 | CSNK1D | 0.34466080 |
| 136 | CAMK4 | 0.34290991 |
| 137 | EGFR | 0.34171866 |
| 138 | MAPKAPK5 | 0.33840461 |
| 139 | PKN1 | 0.32190035 |
| 140 | BMX | 0.31409241 |
| 141 | STK3 | 0.31301811 |
| 142 | SGK2 | 0.30982900 |
| 143 | CHEK2 | 0.30865675 |
| 144 | CSNK1A1L | 0.30844450 |
| 145 | RPS6KA5 | 0.30790167 |
| 146 | FGFR4 | 0.30447831 |
| 147 | PRKACA | 0.29387312 |
| 148 | PIK3CG | 0.29071985 |
| 149 | MKNK2 | 0.28609545 |
| 150 | ABL2 | 0.28404824 |
| 151 | ERN1 | 0.28140065 |
| 152 | GRK5 | 0.28131796 |
| 153 | DAPK1 | 0.27945431 |
| 154 | TNK2 | 0.27483535 |
| 155 | SGK1 | 0.26357137 |
| 156 | PRKCH | 0.26341068 |
| 157 | INSR | 0.25445109 |
| 158 | MYLK | 0.25387077 |
| 159 | MAPK7 | 0.24746918 |
| 160 | MAPK11 | 0.24736392 |
| 161 | NTRK2 | 0.24709515 |
| 162 | ARAF | 0.23679937 |
| 163 | PRKCE | 0.21841667 |
| 164 | PRKG1 | 0.20637660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.28268213 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.13579866 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.13405057 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.77959846 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.77001450 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.67810576 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.63498942 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.50392908 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.49698671 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48059688 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.46588745 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.45321642 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.45106144 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.34931180 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.28662514 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 2.25621824 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24804184 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 2.21240863 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 2.18182853 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 2.07464740 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.06104457 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.04441951 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04212092 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03458192 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.98743891 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96174494 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.95517639 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.93465413 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.89708633 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.89705425 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.89389197 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.88486723 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88125650 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.85797909 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.77091310 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68792073 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.64346501 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.64007722 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.62813697 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.61071149 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58478696 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.57512004 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57158510 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49856818 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49147655 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.48289123 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47653336 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 1.44617342 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42710945 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.42253098 |
| 51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40841516 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.37782847 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 1.37344652 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.33937590 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.31216793 |
| 56 | Homologous recombination_Homo sapiens_hsa03440 | 1.28823112 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28405210 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26571217 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26424831 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23375259 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22882291 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.20319405 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.16003898 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13960108 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 1.13832202 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12278934 |
| 67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12245209 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 1.10260690 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07658733 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 1.07138412 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.06905130 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.06409762 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 1.06372539 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 1.06284295 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05686851 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04613765 |
| 77 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02422799 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00653936 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 1.00176645 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97210176 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.96703598 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95972489 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95721988 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93961544 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93239767 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.91914547 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91255654 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91137900 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90871174 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89896667 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88253198 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85197423 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85129387 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81814035 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79989738 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79406134 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.78514328 |
| 98 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76640378 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.75297051 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73741500 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71867652 |
| 102 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.70195174 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.68620596 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67604417 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.67536915 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.66147193 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65430733 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | 0.64089056 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62106636 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61026682 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60891183 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60441426 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59902929 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57466339 |
| 115 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56413837 |
| 116 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53048365 |
| 117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.52597869 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51808634 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51007990 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50421086 |
| 121 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.50084954 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49972708 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49536886 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.49432066 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48427088 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44987410 |
| 127 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42812785 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42528347 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42374634 |
| 130 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41733765 |
| 131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41601082 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40665697 |
| 133 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40113737 |
| 134 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.38986802 |
| 135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.38045207 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.37848384 |
| 137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34819840 |
| 138 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34095148 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33249621 |
| 140 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33222073 |
| 141 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31939655 |
| 142 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31729187 |
| 143 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31397661 |
| 144 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30938009 |
| 145 | ABC transporters_Homo sapiens_hsa02010 | 0.29835183 |
| 146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29356121 |
| 147 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26332868 |
| 148 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25753454 |
| 149 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22323154 |
| 150 | Mineral absorption_Homo sapiens_hsa04978 | 0.22114970 |
| 151 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22113888 |
| 152 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21185854 |
| 153 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19556806 |
| 154 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19464094 |
| 155 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18828141 |
| 156 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18182735 |
| 157 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.18154174 |
| 158 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17602752 |
| 159 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16492254 |
| 160 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14947069 |
| 161 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.13032253 |
| 162 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12560655 |
| 163 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.12429166 |
| 164 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.11551666 |
| 165 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10088575 |
| 166 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09553943 |
| 167 | Adherens junction_Homo sapiens_hsa04520 | 0.09434555 |

